Vaxcyte, Inc. Share Price
PCVXVaxcyte, Inc. Stock Performance
Open $46.33 | Prev. Close $44.79 | Circuit Range N/A |
Day Range $44.53 - $47.12 | Year Range $27.66 - $93.77 | Volume 65,332 |
Average Traded $45.34 |
Vaxcyte, Inc. Share Price Chart
About Vaxcyte, Inc.
Vaxcyte, Inc., a clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent carrier-sparing investigational pneumococcal conjugate vaccine (PCV) for the prevention of invasive pneumococcal disease (IPD) in infants. The company also develops VAX-31, a 31-valent, carrier-sparing investigational PCV for the prevention of IPD in adults and children; VAX-A1, a novel conjugate vaccine candidate to prevent disease caused by Group A Streptococcus; VAX-PG, a novel protein vaccine candidate targeting the keystone pathogen responsible for periodontitis; and VAX-GI, a novel preclinical vaccine candidate for the treatment of dysentery and shigellosis, which is caused by Shigella bacteria. The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was incorporated in 2013 and is headquartered in San Carlos, California.
Vaxcyte, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
06-Jan-26 | $46.33 | $44.83 | +0.00% |
06-Jan-26 | $46.33 | $44.83 | -2.54% |
05-Jan-26 | $45.57 | $46.00 | -1.00% |
02-Jan-26 | $46.31 | $46.47 | +0.79% |
31-Dec-25 | $45.30 | $46.10 | +1.56% |
30-Dec-25 | $46.23 | $45.39 | -2.51% |
29-Dec-25 | $46.40 | $46.56 | -0.94% |
FAQs on Vaxcyte, Inc. Share Price
Can I buy Vaxcyte, Inc. shares in India?
What is the share price of Vaxcyte, Inc.?
What is the 5 year returns of Vaxcyte, Inc.?
What are the high & low stock price of Vaxcyte, Inc. today?
What is the 52-week high and low of Vaxcyte, Inc. stock?